Abstract:Proteolytic processing of viral polyproteins is indispensible for the lifecycle of coronaviruses. The main protease (M pro ) of SARS-CoV is an attractive target for anti-SARS drug development as it is essential for the polyprotein processing. M pro is initially produced as part of viral polyproteins and it is matured by autocleavage. Here, we report that, with the addition of an N-terminal extension peptide, M pro can form a domain-swapped dimer. After complete removal of the extension peptide from the dimer, the mature M pro self-assembles into a novel super-active octamer (AO-M pro ). The crystal structure of AO-M pro adopts a novel fold with four domain-swapped dimers packing into four active units with nearly identical conformation to that of the previously reported M pro active dimer, and 3D domain swapping serves as a mechanism to lock the active conformation due to entanglement of polypeptide chains. Compared with the previously well characterized form of M pro , in equilibrium between inactive monomer and active dimer, the stable AO-M pro exhibits much higher proteolytic activity at low concentration. As all eight active sites are bound with inhibitors, the polyvalent nature of the interaction between AO-M pro and its polyprotein substrates with multiple cleavage sites, would make AO-M pro functionally much more superior than the M pro active dimer for polyprotein processing. Thus, during the initial period of SARS-CoV infection, this novel active form AOM pro should play a major role in cleaving polyproteins as the protein level is extremely low. The discovery of AOM pro provides new insights about the functional mechanism of M pro and its maturation process.

[Modeling of the SARS Coronavirus Main Proteinase and Conformational Flexibility of the Active Site].

REVISITING THE SARS-COV-2 MAIN PROTEASE: A 2023 IN SILICO ODYSSEY IN SEARCH OF POTENTIAL INHIBITORS

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design.

Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-Like Proteinase

The Substrate Specificity of SARS Coronavirus 3C-Like Proteinase.

Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.

Conformational Flexibility of a Short Loop Near the Active Site of the SARS-3CLpro is Essential to Maintain Catalytic Activity

Ph-Dependent Conformational Flexibility of the SARS-CoV Main Proteinase (mpro) Dimer: Molecular Dynamics Simulations and Multiple X-ray Structure Analyses

Exploring the Efficacy of Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Simulation Analysis Study.

The Conformational Space of the SARS-CoV-2 Main Protease Active Site Loops is Determined by Ligand Binding and Interprotomer Allostery

The Crystal Structures of Severe Acute Respiratory Syndrome Virus Main Protease and Its Complex with an Inhibitor

Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease

Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme.

Only One Protomer is Active in the Dimer of Sars 3C-Like Proteinase

Virtual Screening of Novel Noncovalent Inhibitors for Sars-Cov 3C-Like Proteinase

Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations

Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-Like Proteinase.

Inhibition of the Main Protease 3CL-pro of the Coronavirus Disease 19 via Structure-Based Ligand Design and Molecular Modeling

Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease

Electrostatic and Hydrophobic Interactions in SARS Coronavirus Main Proteinase Dimer